The Mets respond to Putz's allegations

Leave a comment

UPDATE: While I had seen the actual statement the Mets released about Putz before writing the business below, I had missed this story from Marty Noble at MLB.com last night. In it he relates that the Mets do, in fact, deny Putz’s claim that they told him to hide his injuries from the media.  They also say that it’s not standard to do a physical on a player in a trade, only when he’s a free agent.  Whether that means it’s not standard for the Mets to do it or standard for all teams is unclear from the article.

Seems to me, however, that if I was trading for a guy I knew to have bone spurs, I might want to check him out.  But like I said below, I’m not doctor.

4:20 P.M.: Yesterday J.J. Putz alleged that (a) the Mets didn’t give him a physical at the time he was acquired in a trade despite knowing he had a bone spur while pitching for the Mariners; (b) that his spring training physical was a “formality”; and (c) that the Mets told him not to disclose to the media that he was injured after his bone spur flared up again in May. Today the Mets responded:

“In our review of the player’s medical records in the acquisition of
J.J. Putz, we were aware that he had a bone spur before the trade.  He
had the same condition in 2008 and was able to pitch with it.  J.J.
underwent an exam during Spring Training and an additional exam and MRI
before he was cleared to play in last year’s World Baseball Classic. 
Unfortunately the spur did flare up again in May, and he missed the
rest of the season.  We are happy to hear he is feeling well, and wish
him success with the White Sox.”

That’s nice and all, but that doesn’t seem to contradict anything Putz said.  The team admits that they knew about the bone spur. They make no mention of any physical at the time of the trade, so we can assume that the Mets knowingly traded for a guy with bone spurs and did not conduct their own physical of the player.

They agree with Putz that a physical happened during spring training and presumably add the fact of the MRI to contradict Putz’s characterization of it as “a formality,” but neither side suggests that anything relating to bone spurs came up. Rather, they “flared up” in May.  Finally, the team ignores Putz’s charge that they told him not to tell anyone he was hurt.

Look, I’m no doctor, so I can’t say anything intelligent about the bone spurs, when Putz had them when he didn’t and how much trouble they gave him at any given time.  But the flare up, or not, of bone spurs seems like the least troubling part of all of this. More troubling is the lack of a physical at the time of the trade and telling the player not to disclose that he was hurt to the media, neither of which the Mets deny.

Blue Jays sign Michael Saunders

Getty Images
Leave a comment

The Blue Jays have signed outfielder Michael Saunders to a minor-league deal, per a club announcement.

Saunders, of course, played for the Blue Jays in 2015 and 2016, putting up a line of .250/.336/.461 in 594 plate appearances. It was his good play in the first half of 2016, in fact, which earned him an All-Star spot and, presumably, made the Phillies think he was worth the $9 million deal they gave him over the offseason. That didn’t work out, as he hit .205/.257/.360 over 61 games and was released last week.

The Phillies will pay the rest of that $9 million. The Jays will see if he has anything in the tank to help them out.

Giants closer Mark Melancon is heading to the disabled list once again

Getty Images
Leave a comment

The Giants have placed closer Mark Melancon on the 10-day disabled list with a right pronator strain.

This is the same injury that sent him to the disabled list last month. He came back from that quickly, but it can’t be great that this is happening again. You have to assume he’ll miss more time given the recurrence of trouble. He’s going to get an MRI too. Sam Dyson is expected to serve as the Giants’ closer while Melancon is sidelined.

Melancon has a 4.35 ERA and 11 saves in 22 appearances this year. He signed a four-year, $62 million deal with San Francisco last December.